Press releases
curasan AG to co-operate with Kensey Nash Corporation, USA
Distribution of the resorbable membrane EPI-GUIDE® in Europe and the Middle East.
Kleinostheim, 17.
September 2001 - curasan AG, specialist for regenerative bio-medicine
and one of the top companies for marketing in this segment has entered
into a co-operation with Kensey Nash Corporation, Exton, Pennsylvania,
a company quoted on the Nasdaq. The agreement awards curasan the rights
for distributing the CE-certified, resorbable Epi-Guide® membrane
in Europe and the Middle East.
Epi-Guide® is a resorbable membrane, developed for the guided bone
and tissue regeneration in dentistry. It comprises three different layers
which, for one, absorb fluid from the defect and on the other hand encourage
cellular attachment and proliferation within the membrane. The structure
acts as a soft tissue barrier for a minimum of 14 weeks, before resorbing
over time, thus making a second surgical invasion for removal obsolete.
" Epi-Guide®, a highly successful product in the US, optimally
complements our line of membranes and allows us to offer the most adequate
solution for different indications", comments Hans-Dieter Roessler,
CEO of curasan AG, the German-American partnership. Curasan now offers
the most extensive product range in the field of controlled tissue regeneration.
"Curasan has a well-established distribution structure throughout
Europe and the Middle East", says Joe Kaufmann, CEO of Kensey Nash
Corporation, about the strategic cooperation. "We believe the company's
product offerings will make a highly complimentary sale for our Epi-Guide®
product. We are looking forward to a successful relationship."
Background information
on the companies:
curasan AG (WKN 549453), quoted on the New Market segment of the Frankfurt
stock exchange belongs to the leading companies in the future-oriented
field of bone and tissue regeneration. While the business area 'pharmaceuticals'
secures the basis business with above average growth, the future potential
lies in biologicals/biomaterials, especially around Cerasorb®, the
synthetic bone regeneration material. curasan AG has set itself the goal
of reaching the top position as a specialist for regenerative and reparative
bio-medicine in the field of bone and tissue regeneration.